Hsp90 inhibitor NVP-AUY922 enhances radiation sensitivity of tumor cell lines under hypoxia
出版年份 2012 全文链接
标题
Hsp90 inhibitor NVP-AUY922 enhances radiation sensitivity of tumor cell lines under hypoxia
作者
关键词
-
出版物
CANCER BIOLOGY & THERAPY
Volume 13, Issue 6, Pages 425-434
出版商
Informa UK Limited
发表日期
2012-04-03
DOI
10.4161/cbt.19294
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Recent Advances in Hsp90 Inhibitors as Antitumor Agents
- (2012) S. Messaoudi et al. Anti-Cancer Agents in Medicinal Chemistry
- Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins
- (2011) Kyung-Hun Lee et al. CANCER SCIENCE
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
- (2011) Nadine Rohwer et al. DRUG RESISTANCE UPDATES
- Combined effects of novel heat shock protein 90 inhibitor NVP-AUY922 and nilotinib in a random mutagenesis screen
- (2011) T Tauchi et al. ONCOGENE
- Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitise tumour cells through cell-cycle impairment, increased DNA damage and repair protraction
- (2010) L Stingl et al. BRITISH JOURNAL OF CANCER
- Differential response of human glioblastoma cell lines to combined camptothecin and ionizing radiation treatment
- (2010) Cholpon S. Djuzenova et al. CANCER BIOLOGY & THERAPY
- Preclinical Antitumor Activity of the Orally Available Heat Shock Protein 90 Inhibitor NVP-BEP800
- (2010) Andrew J. Massey et al. MOLECULAR CANCER THERAPEUTICS
- Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin
- (2009) X Wu et al. BRITISH JOURNAL OF CANCER
- Targeting HSP90 for cancer therapy
- (2009) D Mahalingam et al. BRITISH JOURNAL OF CANCER
- New developments in Hsp90 inhibitors as anti-cancer therapeutics: Mechanisms, clinical perspective and more potential
- (2009) Yanyan Li et al. DRUG RESISTANCE UPDATES
- Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-d]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone
- (2009) Paul A. Brough et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dual Targeting of HSC70 and HSP72 Inhibits HSP90 Function and Induces Tumor-Specific Apoptosis
- (2008) Marissa V. Powers et al. CANCER CELL
- NVP-AUY922: A Novel Heat Shock Protein 90 Inhibitor Active against Xenograft Tumor Growth, Angiogenesis, and Metastasis
- (2008) S. A. Eccles et al. CANCER RESEARCH
- Synergistic Antipancreatic Tumor Effect by Simultaneously Targeting Hypoxic Cancer Cells With HSP90 Inhibitor and Glycolysis Inhibitor
- (2008) X. Cao et al. CLINICAL CANCER RESEARCH
- Radiosensitization of Human Vascular Endothelial Cells Through Hsp90 Inhibition With 17-N-Allilamino-17-Demethoxygeldanamycin
- (2008) Alexander E. Kabakov et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- ATM Activation and Signaling under Hypoxic Conditions
- (2008) Z. Bencokova et al. MOLECULAR AND CELLULAR BIOLOGY
- HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair
- (2008) T. T. Koll et al. MOLECULAR CANCER THERAPEUTICS
- Cisplatin abrogates the geldanamycin-induced heat shock response
- (2008) Andrea K. McCollum et al. MOLECULAR CANCER THERAPEUTICS
- An optimized method for measurement of gamma-H2AX in blood mononuclear and cultured cells
- (2008) Aida Muslimovic et al. Nature Protocols
- Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and Prognosis
- (2008) P. Vaupel ONCOLOGIST
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started